Q&A with Abridge’s new clinician scientist
Michal Nedoszytko was practicing medicine in Europe but changed careers to work with Abridge.
Analysis of tech, exploring the key drivers, future outlook, and impact of this critical sector on the broader healthcare industry.
Michal Nedoszytko was practicing medicine in Europe but changed careers to work with Abridge.
Sepsis is the third leading cause of death in US hospitals.
As AI continues to push into healthcare, executives reflect on 2026 thus far.
The biggest US deal announced so far was an acquisition by Boston Scientific.
With a slew of new partner deals from Nvidia to Eli Lilly, the startup angles to be more than a scribe.
June recalls that doctors and nurses should know about
Keeping track of personal health data has never been harder.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.